Kyverna Therapeutics published positive registrational trial data for miv-cel, a CAR T-cell therapy, in stiff person syndrome (SPS) patients in JAMA Neurology. The single-dose treatment significantly improved mobility and disability at 16 weeks, with patients stopping chronic immunotherapies and many regaining independent walking ability. Miv-cel demonstrated a strong safety profile with no severe side effects. This marks a potential breakthrough as the first approved therapy for SPS and the first CAR T-cell therapy for autoimmune diseases, with ongoing efforts to bring it to market quickly.
Kyverna Therapeutics' data publication offers context for health-sector stocks on Pluang. As of Nov 09, 2026 22:11 WIB, 107 of 150 health stocks rose, 40 fell. Notable movers include IBRX at USD 6.78 (-21.48%), ARWR at USD 48.52 (-16.57%), and IMVT at USD 34.47 (+12.91%).
Nokia Corporation transferred 847,057 of its own shares to participants of its equity-based incentive plans without any payment, following a board resolution. This transfer fulfills Nokia's commitments under these plans and reduces the company's own ...
Nokia has transferred 847,057 of its treasury shares to employees participating in its stock-based incentive programs, as per a board decision announced in October 2025. This transfer was done without compensation, fulfilling commitments under the in...
Silvercrest Asset Management Group Inc. was ranked #8 in Nasdaq eVestment’s Q3 2026 Brand Awareness Rankings among mid-sized firms managing $2.5 billion to $40 billion in assets. This ranking reflects strong engagement from consultants and asset owne...
The Software Safety Institute (SSI), a new independent nonprofit, has launched to tackle preventable harm caused by unsafe and insecure software. SSI aims to improve software safety by changing industry incentives and practices through research, publ...
AST SpaceMobile is set to report its Q3 2026 earnings with an expected loss of $0.42 per share and revenue of $45.7 million. The company is advancing its satellite network technology, including a new joint venture with Rakuten to build a direct-to-de...
